TECH
Bio-Techne Corp
72.40$
-0.1%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 23.3% | 22.5% | 22.2% | 25.0% | 21.9% | 25.7% | 22.6% | 26.4% | 23.6% | 22.8% | 23.8% | 27.8% | |
| 5.1% | 5.7% | 5.9% | 7.7% | 5.4% | 7.2% | 8.8% | 7.5% | 6.8% | 5.6% | 6.3% | 9.9% | |
| 10.4% | 8.5% | 10.1% | 11.4% | 8.8% | 13.4% | 10.2% | 10.8% | 7.7% | 5.7% | 6.3% | 9.9% | |
| 6.6% | 8.3% | 7.5% | 7.6% | 7.3% | 6.0% | 6.4% | 8.5% | 8.3% | 8.9% | 8.1% | 8.2% | |
| 4.7% | 5.1% | 3.9% | 5.4% | 4.8% | 5.1% | 5.2% | 6.1% | 6.5% | 6.6% | 7.4% | 7.3% | |
| 12.2% | 11.7% | 8.7% | 9.1% | 8.2% | 12.2% | 12.5% | 12.6% | 8.6% | – | – | – | |
| 36.7% | 38.1% | 37.2% | 37.5% | 38.9% | 35.9% | 37.3% | 35.8% | 33.1% | 36.0% | 38.3% | 36.4% | |
| 27.5% | 27.5% | 29.0% | 28.0% | 30.7% | 25.5% | 27.2% | 23.2% | 20.3% | 18.8% | 14.3% | 11.3% | |
| 20.4% | 22.2% | 38.9% | 32.3% | 38.1% | 31.9% | 30.6% | 25.9% | 25.5% | 23.5% | 25.0% | 21.3% | |
| 3.7% | 4.8% | 8.7% | 4.9% | 5.4% | 5.3% | 6.7% | 7.7% | 4.9% | 5.9% | 6.9% | 6.1% | |
| 0.4% | 0.3% | 0.4% | 0.6% | 0.7% | 1.1% | 1.1% | 1.1% | 0.4% | 0.5% | 0.6% | 0.6% | |
| 1.3% | 1.8% | 1.1% | 4.0% | 0.9% | 1.1% | 1.3% | 1.5% | 1.0% | 1.4% | 1.0% | 1.0% | |
| 6.9% | 8.1% | 22.1% | 21.3% | 26.1% | 17.0% | 14.5% | 10.6% | 13.3% | 11.8% | 13.5% | 7.5% | |
| 79.6% | 77.8% | 61.1% | 67.7% | 61.9% | 68.1% | 69.1% | 74.2% | 74.5% | 76.5% | 75.0% | 78.7% | |
| 67.1% | 68.2% | 51.3% | 55.0% | 49.5% | 52.2% | 48.0% | 48.9% | 49.6% | 49.0% | 41.7% | 42.7% | |
| 14.0% | 13.2% | 9.6% | 9.6% | 8.3% | 7.8% | 7.2% | 7.2% | 6.1% | 5.9% | 6.2% | 5.9% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.